
Molsidomine, a nitric oxide donor, modulates rotational behavior and monoamine metabolism in 6-OHDA lesioned rats treated chronically with L-DOPA
Keywords: 6-OHDA animal model of Parkinson's disease; Dopamine and serotonin metabolism; L-DOPA; Molsidomine; Nitric oxide; Rotational behavior; ANOVA; analysis of variance; DA; dopamine; DOPAC; 3,4-dihydroxyphenylacetic acid; HPLC; high-pressure liquid chromatog